Role of the XRCC5/XRCC6 dimer in carcinogenesis and pharmacogenomics

Author： Bau Da-Tian   Tsai Chia-Wen   Wu Cheng-Nan  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.12, Iss.4, 2011-04, pp. : 515-534

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

CYP2A6 polymorphisms: is there a role for pharmacogenomics in preventing coumarin-induced hepatotoxicity in lymphedema patients?

By Farinola Nicholas   Piller Neil B  

Pharmacogenomics, Vol. 8, Iss. 2, 2007-02 ,pp. : 151-158

Future Medicine

Access to resources Recommend Favorite

The Co-regulatory Role of 5-Lipoxygenase and Cyclooxygenase-2 in the Carcinogenesis and their Promotion by Cigarette Smoking in Colons

By  

Current Medicinal Chemistry, Vol. 23, Iss. 11, 2016-04 ,pp. : 1131-1138

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Pharmacogenomics in Individualising Treatment with SSRIs

By Mancama D.   Kerwin R.W.  

CNS Drugs, Vol. 17, Iss. 3, 2003-01 ,pp. : 143-151

Adis International

Access to resources Recommend Favorite

Role and Pharmacogenomics of TNF- in Asthma

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 9, 2008-08 ,pp. : 934-942

Bentham Science Publishers

Access to resources Recommend Favorite

Role of DNA Adducts in Hormonal Carcinogenesis

By Liehr J.G.  

Regulatory Toxicology and Pharmacology, Vol. 32, Iss. 3, 2000-12 ,pp. : 276-282

Academic Press

Access to resources Recommend Favorite